Type
. Interventions for Stigma Reduction – Part 1: Theoretical Considerations. Disability, CBR and Inclusive Development [Internet]. 2011;22(3). Available from: http://dcidj.org/article/view/70
Type
. Interventions for stigma reduction – Part 2: practical applications. Disability, CBR and Inclusive Development [Internet]. 2011;22(3). Available from: http://dcidj.org/article/view/72
Type
. The face of disability in Nigeria : A Disability survey in Kogi and Niger states. Disability, CBR and Inclusive Development [Internet]. 2011;22(1). Available from: http://dcidj.org/article/view/11
Type
. Drug-resistant leprosy: monitoring and current status. Leprosy review [Internet]. 2012;83(3):269-81. Available from: https://leprosyreview.org/article/83/3/00-269
Type
. Developing new MDT regimens for MB patients; time to test ROM 12 month regimens globally. Leprosy review [Internet]. 2012;83(3):241-4. Available from: https://leprosyreview.org/article/83/3/00-241
Type
. Biological agents: investigation into leprosy and other infectious diseases before indication. Anais brasileiros de dermatologia [Internet]. 2013;88(6 Suppl 1):23-5. Available from: http://www.scielo.br/pdf/abd/v88n6s1/0365-0596-abd-88-06-s1-0023.pdf
Type
. Recurrence of lepromatous leprosy in a patient with intolerance of dapsone. Journal of the American Academy of Dermatology. 2013;68(4 ):AB60 -.
Type
. Serial measurement of the circulating levels of tumour necrosis factor and its soluble receptors 1 and 2 for monitoring leprosy patients during multidrug treatment. [Internet]. 2013;108(8):1051-1056. Available from: http://www.scielo.br/pdf/mioc/v108n8/0074-0276-mioc-108-8-1051.pdf
Type
. [Chronic borderline tuberculoid leprosy]. Annales de dermatologie et de vénéréologie. 2014;141(5):399-401.
Type
. Nontraumatic hypertrophic neuroma in treated Hansen disease. Neurology [Internet]. 2014;82:93-94. Available from: http://www.neurology.org/content/82/1/93.full.pdf+html